{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:24:17Z","timestamp":1793154257370,"version":"4.5.0"},"reference-count":200,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","award":["2022JH2\/20200033"],"award-info":[{"award-number":["2022JH2\/20200033"]}],"id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Liaoning Province Supported China Medical University High-quality Development Fund Project in 2022"},{"DOI":"10.13039\/501100005047","name":"Liaoning Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["JYTMS20230129"],"award-info":[{"award-number":["JYTMS20230129"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005047","name":"Liaoning Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2024-MS-025"],"award-info":[{"award-number":["2024-MS-025"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jare.2025.06.024","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T19:45:24Z","timestamp":1749843924000},"page":"733-756","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["FGFs\/FGFRs and neuroinflammatory diseases: mechanism, drug therapies and delivery systems"],"prefix":"10.1016","volume":"78","author":[{"given":"Juan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3972-2911","authenticated-orcid":false,"given":"Yue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinzhuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoxiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benyu","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luoxuan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jare.2025.06.024_b0005","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3389\/fphar.2020.00480","article-title":"Editorial: neuroinflammation and its resolution: from molecular mechanisms to therapeutic perspectives","volume":"11","author":"Zusso","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jare.2025.06.024_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115119","article-title":"Emerging drug delivery systems with traditional routes - a roadmap to chronic inflammatory diseases","volume":"203","author":"Min","year":"2023","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jare.2025.06.024_b0015","article-title":"Review of liposomes as a drug delivery system: current status of approved products, regulatory environments, and future perspectives","volume":"27","author":"Liu","year":"2022","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"2","key":"10.1016\/j.jare.2025.06.024_b0020","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cytogfr.2005.01.008","article-title":"Structural basis for fibroblast growth factor receptor activation","volume":"16","author":"Mohammadi","year":"2005","journal-title":"Cytokine Growth Factor Rev"},{"issue":"6","key":"10.1016\/j.jare.2025.06.024_b0025","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00018-010-0576-3","article-title":"Biology of FGFRL1, the fifth fibroblast growth factor receptor","volume":"68","author":"Trueb","year":"2011","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"10.1016\/j.jare.2025.06.024_b0030","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0378-1119(01)00518-2","article-title":"Identification of a new fibroblast growth factor receptor, FGFR5","volume":"271","author":"Sleeman","year":"2001","journal-title":"Gene"},{"issue":"2","key":"10.1016\/j.jare.2025.06.024_b0035","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nrc2780","article-title":"Fibroblast growth factor signalling: from development to cancer","volume":"10","author":"Turner","year":"2010","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"10.1016\/j.jare.2025.06.024_b0040","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/wdev.176","article-title":"The fibroblast growth factor signaling pathway","volume":"4","author":"Ornitz","year":"2015","journal-title":"Wiley Interdiscip Rev Dev Biol"},{"issue":"2","key":"10.1016\/j.jare.2025.06.024_b0045","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0092-8674(94)90302-6","article-title":"Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia","volume":"78","author":"Shiang","year":"1994","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.jare.2025.06.024_b0050","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1182\/blood.V92.9.3025","article-title":"The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH\/MMSET hybrid transcripts","volume":"92","author":"Chesi","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jare.2025.06.024_b0055","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jbior.2014.10.003","article-title":"Lipid rafts as major platforms for signaling regulation in cancer","volume":"57","author":"Mollinedo","year":"2015","journal-title":"Adv Biol Regul"},{"issue":"4","key":"10.1016\/j.jare.2025.06.024_b0060","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/hmg\/dds486","article-title":"Oncogenic FGFR3 gene fusions in bladder cancer","volume":"22","author":"Williams","year":"2013","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jare.2025.06.024_b0065","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/1471-2148-9-226","article-title":"FGFRL1 is a neglected putative actor of the FGF signalling pathway present in all major metazoan phyla","volume":"9","author":"Bertrand","year":"2009","journal-title":"BMC Evol Biol"},{"key":"10.1016\/j.jare.2025.06.024_b0070","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cytogfr.2024.07.002","article-title":"Quantitative and qualitative differences in the activation of a fibroblast growth factor receptor by different FGF ligands","volume":"78","author":"Krzyscik","year":"2024","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jare.2025.06.024_b0075","article-title":"Basic fibroblast growth factor (bFGF) protects the blood-brain barrier by binding of FGFR1 and activating the ERK signaling pathway after intra-abdominal hypertension and traumatic brain injury","volume":"26","author":"Chen","year":"2020","journal-title":"Med Sci Monit: Int Med J Exp Clin Res"},{"issue":"5","key":"10.1016\/j.jare.2025.06.024_b0080","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.biopsych.2006.10.019","article-title":"Fibroblast growth factor receptor-1 is required for long-term potentiation, memory consolidation, and neurogenesis","volume":"62","author":"Zhao","year":"2007","journal-title":"Biol Psychiatry"},{"issue":"7","key":"10.1016\/j.jare.2025.06.024_b0085","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2174\/1389203715666140901112245","article-title":"Interactions between cholinergic and fibroblast growth factor receptors in brain trophism and plasticity","volume":"15","author":"Di Liberto","year":"2014","journal-title":"Curr Protein Pept Sci"},{"issue":"1","key":"10.1016\/j.jare.2025.06.024_b0090","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s12035-014-9037-6","article-title":"Immunomodulator CD200 promotes neurotrophic activity by Interacting with and activating the fibroblast growth factor receptor","volume":"53","author":"Pankratova","year":"2016","journal-title":"Mol Neurobiol"},{"issue":"9","key":"10.1016\/j.jare.2025.06.024_b0095","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.15252\/embj.201490578","article-title":"FGF22 signaling regulates synapse formation during post-injury remodeling of the spinal cord","volume":"34","author":"Jacobi","year":"2015","journal-title":"EMBO J"},{"key":"10.1016\/j.jare.2025.06.024_b0100","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1742-2094-11-76","article-title":"FGF-2 released from degenerating neurons exerts microglial-induced neuroprotection via FGFR3-ERK signaling pathway","volume":"11","author":"Noda","year":"2014","journal-title":"J. Neuroinflammation"},{"issue":"4","key":"10.1016\/j.jare.2025.06.024_b0105","doi-asserted-by":"crossref","DOI":"10.3390\/cells12040528","article-title":"Up-regulation of astrocytic Fgfr4 expression in adult mice after spinal cord injury","volume":"12","author":"Bringuier","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.jare.2025.06.024_b0110","doi-asserted-by":"crossref","unstructured":"Alhajlah SJJoP, Sciences B. Suppression of Fibroblast Growth Factor Receptor-5 (FGFR5) has no Impact on Axon Regeneration after SCI. 2023;15(Suppl 2):S1111-S5.","DOI":"10.4103\/jpbs.jpbs_199_23"},{"issue":"7966","key":"10.1016\/j.jare.2025.06.024_b0115","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/s41586-023-06155-9","article-title":"Structural basis for FGF hormone signalling","volume":"618","author":"Chen","year":"2023","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jare.2025.06.024_b0120","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S1097-2765(00)00073-3","article-title":"Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization","volume":"6","author":"Schlessinger","year":"2000","journal-title":"Mol Cell"},{"issue":"23","key":"10.1016\/j.jare.2025.06.024_b0125","doi-asserted-by":"crossref","first-page":"15694","DOI":"10.1074\/jbc.M601252200","article-title":"Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family","volume":"281","author":"Zhang","year":"2006","journal-title":"J Biol Chem"},{"issue":"36","key":"10.1016\/j.jare.2025.06.024_b0130","doi-asserted-by":"crossref","first-page":"34226","DOI":"10.1074\/jbc.M303183200","article-title":"Fibroblast growth factor (FGF) homologous factors share structural but not functional homology with FGFs","volume":"278","author":"Olsen","year":"2003","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.jare.2025.06.024_b0135","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0012-1606(92)90143-5","article-title":"Effects of acidic and basic fibroblast growth factors (aFGF, bFGF) on glial precursor cell proliferation: age dependency and brain region specificity","volume":"152","author":"Engele","year":"1992","journal-title":"Dev Biol"},{"issue":"5","key":"10.1016\/j.jare.2025.06.024_b0140","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0361-9230(94)90075-2","article-title":"Acidic fibroblast growth factor facilitates generation of long-term potentiation in rat hippocampal slices","volume":"33","author":"Sasaki","year":"1994","journal-title":"Brain Res Bull"},{"issue":"1","key":"10.1016\/j.jare.2025.06.024_b0145","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0006-8993(93)90295-X","article-title":"Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF","volume":"621","author":"Mattson","year":"1993","journal-title":"Brain Res"},{"key":"10.1016\/j.jare.2025.06.024_b0150","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/978-1-4615-0123-7_12","article-title":"Fibroblast growth factors and neuroprotection","volume":"513","author":"Alzheimer","year":"2002","journal-title":"Adv Exp Med Biol"},{"issue":"9","key":"10.1016\/j.jare.2025.06.024_b0155","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1096\/fj.05-5293fje","article-title":"FGF-4 regulates neural progenitor cell proliferation and neuronal differentiation","volume":"20","author":"Kosaka","year":"2006","journal-title":"FASEB J"},{"issue":"20","key":"10.1016\/j.jare.2025.06.024_b0160","doi-asserted-by":"crossref","first-page":"8022","DOI":"10.1073\/pnas.87.20.8022","article-title":"Expression of the murine fibroblast growth factor 5 gene in the adult central nervous system","volume":"87","author":"Haub","year":"1990","journal-title":"PNAS"},{"key":"10.1016\/j.jare.2025.06.024_b0165","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3389\/fncel.2020.00237","article-title":"FGF5 regulates schwann cell migration and adhesion","volume":"14","author":"Chen","year":"2020","journal-title":"Front Cell Neurosci"},{"issue":"23","key":"10.1016\/j.jare.2025.06.024_b0170","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1111\/jcmm.17934","article-title":"Fibroblast growth factor 5 protects against spinal cord injury through activating AMPK pathway","volume":"27","author":"Chen","year":"2023","journal-title":"J Cell Mol Med"},{"issue":"9","key":"10.1016\/j.jare.2025.06.024_b0175","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/jnr.21323","article-title":"Long-term delivery of FGF-6 changes the fiber type and fatigability of muscle reinnervated from embryonic neurons transplanted into adult rat peripheral nerve","volume":"85","author":"Grumbles","year":"2007","journal-title":"J Neurosci Res"},{"issue":"19","key":"10.1016\/j.jare.2025.06.024_b0180","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914998","article-title":"FGF3 directs the pathfinding of prethalamic GABAergic axons","volume":"24","author":"Huang","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"13","key":"10.1016\/j.jare.2025.06.024_b0185","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0960-9822(02)00899-0","article-title":"Establishment of hindbrain segmental identity requires signaling by FGF3 and FGF8","volume":"12","author":"Walshe","year":"2002","journal-title":"Curr Biol"},{"key":"10.1016\/j.jare.2025.06.024_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2024.e00383","article-title":"Fibroblast growth factor 3 contributes to neuropathic pain through Akt\/mTOR signaling in mouse primary sensory neurons","author":"Guo","year":"2024","journal-title":"Neurotherapeutics"},{"issue":"2","key":"10.1016\/j.jare.2025.06.024_b0195","first-page":"281","article-title":"Selective synaptic targeting of the excitatory and inhibitory presynaptic organizers FGF22 and FGF7","volume":"128","author":"Terauchi","year":"2015","journal-title":"J Cell Sci"},{"key":"10.1016\/j.jare.2025.06.024_b0200","doi-asserted-by":"crossref","DOI":"10.1242\/dev.203123","article-title":"Distinct sets of FGF receptors sculpt excitatory and inhibitory synaptogenesis","volume":"151","author":"Dabrowski","year":"2024","journal-title":"Development (Cambridge, England)"},{"key":"10.1016\/j.jare.2025.06.024_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134685","article-title":"FGF10 regulates thalamocortical axon guidance in the developing thalamus","volume":"716","author":"Liu","year":"2020","journal-title":"Neurosci Lett"},{"issue":"13","key":"10.1016\/j.jare.2025.06.024_b0210","doi-asserted-by":"crossref","DOI":"10.1242\/dev.180950","article-title":"Fibroblast growth factor 10 is a negative regulator of postnatal neurogenesis in the mouse hypothalamus","volume":"147","author":"Goodman","year":"2020","journal-title":"Development"},{"key":"10.1016\/j.jare.2025.06.024_b0215","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neuroscience.2022.07.033","article-title":"FGF 10 inhibited spinal microglial activation in neuropathic pain via PPAR-\u03b3\/NF-\u03baB signaling","volume":"500","author":"Bian","year":"2022","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.jare.2025.06.024_b0220","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2023.13024","article-title":"Delivery of FGF10 by implantable porous gelatin microspheres for treatment of spinal cord injury","volume":"28","author":"Gu","year":"2023","journal-title":"Mol Med Rep"},{"issue":"10","key":"10.1016\/j.jare.2025.06.024_b0225","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1242\/dev.115568","article-title":"Distinct sets of FGF receptors sculpt excitatory and inhibitory synaptogenesis","volume":"142","author":"Dabrowski","year":"2015","journal-title":"Development"},{"issue":"2","key":"10.1016\/j.jare.2025.06.024_b0230","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/WNR.0000000000001399","article-title":"Neuronal fibroblast growth factor 22 signaling during development, but not in adults, is involved in anhedonia","volume":"31","author":"Terauchi","year":"2020","journal-title":"Neuroreport"},{"issue":"2","key":"10.1016\/j.jare.2025.06.024_b0235","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202216111","article-title":"Synaptogenic gene therapy with FGF22 improves circuit plasticity and functional recovery following spinal cord injury","volume":"15","author":"Aljovi\u0107","year":"2023","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jare.2025.06.024_b0240","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bbrc.2023.09.070","article-title":"Fgf22 and Fgfr2b are required for neurogenesis and gliogenesis in the zebrafish forebrain","volume":"681","author":"Miyake","year":"2023","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jare.2025.06.024_b0245","series-title":"Development and function is FGF8 signaling dependent","author":"Astrocyte","year":"2019"},{"key":"10.1016\/j.jare.2025.06.024_b0250","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1749-8104-3-17","article-title":"FGF15 promotes neurogenesis and opposes FGF8 function during neocortical development","volume":"3","author":"Borello","year":"2008","journal-title":"Neural Dev"},{"issue":"3","key":"10.1016\/j.jare.2025.06.024_b0255","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1601-183X.2007.00357.x","article-title":"Abnormal social behaviors in mice lacking Fgf17","volume":"7","author":"Scearce-Levie","year":"2008","journal-title":"Genes Brain Behav"},{"issue":"7910","key":"10.1016\/j.jare.2025.06.024_b0260","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41586-022-04722-0","article-title":"Young CSF restores oligodendrogenesis and memory in aged mice via Fgf17","volume":"605","author":"Iram","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jare.2025.06.024_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176521","article-title":"FGF17 protects cerebral ischemia reperfusion-induced blood-brain barrier disruption via FGF receptor 3-mediated PI3K\/AKT signaling pathway","volume":"971","author":"Huang","year":"2024","journal-title":"Eur J Pharmacol"},{"issue":"1\u20132","key":"10.1016\/j.jare.2025.06.024_b0270","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0169-328X(02)00393-5","article-title":"FGF-18 is a neuron-derived glial cell growth factor expressed in the rat brain during early postnatal development","volume":"105","author":"Hoshikawa","year":"2002","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.jare.2025.06.024_b0275","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.neuroscience.2017.05.007","article-title":"FGF18 protects against 6-hydroxydopamine-induced nigrostriatal damage in a rat model of Parkinson\u2019s disease","volume":"356","author":"Guo","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.jare.2025.06.024_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2023.102367","article-title":"FGF-18 alleviates memory impairments and neuropathological changes in a rat model of Alzheimer\u2019s disease","volume":"101","author":"Ciltas","year":"2023","journal-title":"Neuropeptides"},{"issue":"1","key":"10.1016\/j.jare.2025.06.024_b0285","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s12035-023-03503-8","article-title":"FGF-18 protects the injured spinal cord in mice by suppressing pyroptosis and promoting autophagy via the AKT-mTOR-TRPML1 axis","volume":"61","author":"Li","year":"2024","journal-title":"Mol Neurobiol"},{"issue":"34","key":"10.1016\/j.jare.2025.06.024_b0290","doi-asserted-by":"crossref","first-page":"29134","DOI":"10.1074\/jbc.M112.342980","article-title":"Conversion of a paracrine fibroblast growth factor into an endocrine fibroblast growth factor","volume":"287","author":"Goetz","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jare.2025.06.024_b0295","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cyto.2018.02.013","article-title":"Alteration in the serum concentrations of FGF19, FGFR4 and \u03b2Klotho in patients with thyroid cancer","volume":"105","author":"Motylewska","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.jare.2025.06.024_b0300","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2193-1801-3-2","article-title":"Fibroblast growth factor-21 enhances mitochondrial functions and increases the activity of PGC-1\u03b1 in human dopaminergic neurons via Sirtuin-1","volume":"3","author":"M\u00e4kel\u00e4","year":"2014","journal-title":"Springerplus"},{"key":"10.1016\/j.jare.2025.06.024_b0305","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.pbb.2015.03.020","article-title":"Fibroblast growth factor 21 protects mouse brain against D-galactose induced aging via suppression of oxidative stress response and advanced glycation end products formation","volume":"133","author":"Yu","year":"2015","journal-title":"Pharmacol Biochem Behav"},{"issue":"4","key":"10.1016\/j.jare.2025.06.024_b0310","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.1111\/ejn.15375","article-title":"Localization of fibroblast growth factor 23 protein in the rat hypothalamus","volume":"54","author":"Ursem","year":"2021","journal-title":"Eur J Neurosci"},{"issue":"2","key":"10.1016\/j.jare.2025.06.024_b0315","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1006\/bbrc.2000.3696","article-title":"Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain","volume":"277","author":"Yamashita","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jare.2025.06.024_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.autneu.2020.102640","article-title":"Rostral ventrolateral medulla neuron activity is suppressed by klotho and stimulated by FGF23 in newborn Wistar rats","volume":"224","author":"Oshima","year":"2020","journal-title":"Auton Neurosci"},{"issue":"9","key":"10.1016\/j.jare.2025.06.024_b0325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203460","article-title":"Fibroblast growth factor23 is associated with axonal integrity and neural network architecture in the human frontal lobes","volume":"13","author":"Marebwa","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jare.2025.06.024_b0330","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.brainres.2011.07.028","article-title":"Impairment of spatial learning and memory in transgenic mice overexpressing human fibroblast growth factor-23","volume":"1412","author":"Liu","year":"2011","journal-title":"Brain Res"},{"key":"10.1016\/j.jare.2025.06.024_b0335","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.arr.2017.03.003","article-title":"The relevance of \u03b1-KLOTHO to the central nervous system: some key questions","volume":"36","author":"Cararo-Lopes","year":"2017","journal-title":"Ageing Res Rev"},{"issue":"1","key":"10.1016\/j.jare.2025.06.024_b0340","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/dvdy.21388","article-title":"Functional evolutionary history of the mouse Fgf gene family","volume":"237","author":"Itoh","year":"2008","journal-title":"Dev Dyn"},{"issue":"12","key":"10.1016\/j.jare.2025.06.024_b0345","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1007\/s11427-012-4412-x","article-title":"Roles of intracellular fibroblast growth factors in neural development and functions","volume":"55","author":"Zhang","year":"2012","journal-title":"Sci China Life Sci"},{"issue":"17","key":"10.1016\/j.jare.2025.06.024_b0350","doi-asserted-by":"crossref","first-page":"9495","DOI":"10.3390\/ijms22179495","article-title":"Oligodendrocyte-specific deletion of FGFR1 reduces cerebellar inflammation and neurodegeneration in MOG35-55-induced EAE","volume":"22","author":"Rajendran","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.jare.2025.06.024_b0355","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/bpa.12487","article-title":"Oligodendroglial fibroblast growth factor receptor 1 gene targeting protects mice from experimental autoimmune encephalomyelitis through ERK\/AKT phosphorylation","volume":"28","author":"Rajendran","year":"2018","journal-title":"Brain Pathol (Zurich, Switzerland)"},{"key":"10.1016\/j.jare.2025.06.024_b0360","unstructured":"Rajendran R. Evaluation of the fibroblast growth factor receptor 1 (FGFR1) in experimental autoimmune encephalomyelitis (EAE). 2014."},{"issue":"2","key":"10.1016\/j.jare.2025.06.024_b0365","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/bpa.12916","article-title":"Oligodendrocyte-specific deletion of FGFR2 ameliorates MOG(35-55) -induced EAE through ERK and Akt signalling","volume":"31","author":"Kamali","year":"2021","journal-title":"Brain Pathol (Zurich, Switzerland)"},{"issue":"Pt 7","key":"10.1016\/j.jare.2025.06.024_b0370","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1093\/brain\/awv102","article-title":"Fibroblast growth factor signalling in multiple sclerosis: inhibition of myelination and induction of pro-inflammatory environment by FGF9","volume":"138","author":"Lindner","year":"2015","journal-title":"Brain J Neurol"},{"key":"10.1016\/j.jare.2025.06.024_b0375","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1742-2094-7-81","article-title":"Hippocampal FGF-2 and BDNF overexpression attenuates epileptogenesis-associated neuroinflammation and reduces spontaneous recurrent seizures","volume":"7","author":"Bovolenta","year":"2010","journal-title":"J Neuroinflammation"},{"issue":"8","key":"10.1016\/j.jare.2025.06.024_b0380","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25084160","article-title":"Lack of direct effects of neurotrophic factors in an in vitro model of neuroinflammation","volume":"25","author":"Aziz","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jare.2025.06.024_b0385","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.903235","article-title":"Coeloglossum viride Var. Bracteatum extract attenuates MPTP-induced neurotoxicity in vivo by restoring BDNF-TrkB and FGF2-Akt signaling axis and inhibiting RIP1-driven inflammation","volume":"13","author":"Lang","year":"2022","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.jare.2025.06.024_b0390","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/s12640-019-00151-6","article-title":"FGF21 protects dopaminergic neurons in Parkinson\u2019s disease models via repression of neuroinflammation","volume":"37","author":"Fang","year":"2020","journal-title":"Neurotox Res"},{"issue":"10","key":"10.1016\/j.jare.2025.06.024_b0395","doi-asserted-by":"crossref","first-page":"8643","DOI":"10.1002\/jcb.27105","article-title":"FGF9 modulates schwann cell myelination in developing nerves and induces a pro-inflammatory environment during injury","volume":"119","author":"Deng","year":"2018","journal-title":"J Cell Biochem"},{"issue":"1","key":"10.1016\/j.jare.2025.06.024_b0400","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s13311-020-00933-3","article-title":"Behavioral, hormonal, inflammatory, and metabolic effects associated with FGF21-pathway activation in an ALS mouse model","volume":"18","author":"Delaye","year":"2021","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jare.2025.06.024_b0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2024.149017","article-title":"Ultrasoft bioadhesive hydrogel as a versatile platform for the delivery of basic fibroblast growth factor to repair traumatic brain injury","volume":"483","author":"Shen","year":"2024","journal-title":"Chem Eng J"},{"issue":"4\u20136","key":"10.1016\/j.jare.2025.06.024_b0410","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000511381","article-title":"FGF10 attenuates Experimental traumatic brain injury through TLR4\/MyD88\/NF-\u03baB pathway","volume":"209","author":"Hou","year":"2020","journal-title":"Cells Tissues Organs"},{"key":"10.1016\/j.jare.2025.06.024_b0415","article-title":"FGF20 protected against BBB disruption after traumatic brain injury by upregulating junction protein expression and inhibiting the inflammatory response","volume":"11","author":"Chen","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jare.2025.06.024_b0420","doi-asserted-by":"crossref","unstructured":"Rehman R, Froehlich A, olde Heuvel F, Elsayed L, Boeckers T, Huber-Lang M, et al. The FGFR inhibitor Rogaratinib reduces microglia reactivity and synaptic loss in TBI. 2024:2024.06.03.597197.","DOI":"10.1101\/2024.06.03.597197"},{"issue":"1","key":"10.1016\/j.jare.2025.06.024_b0425","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12974-022-02681-x","article-title":"The FGF\/FGFR system in the microglial neuroinflammation with Borrelia burgdorferi: likely intersectionality with other neurological conditions","volume":"20","author":"Parthasarathy","year":"2023","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.jare.2025.06.024_b0430","doi-asserted-by":"crossref","unstructured":"Parthasarathy GJFiI. Fibroblast growth factor receptor inhibitors mitigate the neuropathogenicity of Borrelia burgdorferi or its remnants ex vivo. 2024;15:1327416.","DOI":"10.3389\/fimmu.2024.1327416"},{"key":"10.1016\/j.jare.2025.06.024_b0435","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bcp.2019.06.025","article-title":"FGF-2 signaling activation in the hippocampus contributes to the behavioral and cellular responses to puerarin","volume":"168","author":"Cheng","year":"2019","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jare.2025.06.024_b0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114046","article-title":"Paeoniflorin exerts antidepressant-like effects through enhancing neuronal FGF-2 by microglial inactivation","volume":"274","author":"Cheng","year":"2021","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.jare.2025.06.024_b0445","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3389\/fncel.2018.00255","article-title":"Fibroblast growth factor 2 modulates hippocampal microglia activation in a neuroinflammation induced model of depression","volume":"12","author":"Tang","year":"2018","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.jare.2025.06.024_b0450","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.bbi.2017.05.013","article-title":"Exogenous FGF2 reverses depressive-like behaviors and restores the suppressed FGF2-ERK1\/2 signaling and the impaired hippocampal neurogenesis induced by neuroinflammation","volume":"66","author":"Tang","year":"2017","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.jare.2025.06.024_b0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchemneu.2020.101872","article-title":"MiR-497 promotes microglia activation and proinflammatory cytokines production in chronic unpredictable stress-induced depression via targeting FGF2","volume":"110","author":"Zhai","year":"2020","journal-title":"J Chem Neuroanat"},{"key":"10.1016\/j.jare.2025.06.024_b0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173297","article-title":"Involvement of FGF-2 modulation in the antidepressant-like effects of liquiritin in mice","volume":"881","author":"Chen","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jare.2025.06.024_b0465","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3389\/fphar.2020.00154","article-title":"FGF21 attenuated LPS-induced depressive-like behavior via inhibiting the inflammatory pathway","volume":"11","author":"Wang","year":"2020","journal-title":"Front Pharmacol"},{"issue":"11","key":"10.1016\/j.jare.2025.06.024_b0470","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/cns.12760","article-title":"Fibroblast growth factor 22 is a novel modulator of depression through interleukin-1\u03b2","volume":"23","author":"Xu","year":"2017","journal-title":"CNS Neurosci Ther"},{"issue":"2","key":"10.1016\/j.jare.2025.06.024_b0475","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ejp.1119","article-title":"New approach for the treatment of neuropathic pain: fibroblast growth factor 1 gene-transfected adipose-derived mesenchymal stem cells","volume":"22","author":"Forouzanfar","year":"2018","journal-title":"Eur J Pain (London, England)"},{"issue":"8","key":"10.1016\/j.jare.2025.06.024_b0480","first-page":"2898","article-title":"Spinal astrocytic FGFR3 activation leads to mechanical hypersensitivity by increased TNF-\u03b1 in spared nerve injury","volume":"12","author":"Xie","year":"2019","journal-title":"Int J Clin Exp Path"},{"issue":"17","key":"10.1016\/j.jare.2025.06.024_b0485","doi-asserted-by":"crossref","first-page":"4785","DOI":"10.1523\/JNEUROSCI.4195-15.2016","article-title":"FGF-1 triggers pannexin-1 hemichannel opening in spinal astrocytes of rodents and promotes inflammatory responses in acute spinal cord slices","volume":"36","author":"Garr\u00e9","year":"2016","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.jare.2025.06.024_b0490","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/brb3.172","article-title":"Fgf2 improves functional recovery-decreasing gliosis and increasing radial glia and neural progenitor cells after spinal cord injury","volume":"4","author":"Goldshmit","year":"2014","journal-title":"Brain Behav"},{"key":"10.1016\/j.jare.2025.06.024_b0495","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.molimm.2022.03.007","article-title":"Exosomal miR-9-5p derived from BMSCs alleviates apoptosis, inflammation and endoplasmic reticulum stress in spinal cord injury by regulating the HDAC5\/FGF2 axis","volume":"145","author":"He","year":"2022","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jare.2025.06.024_b0500","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.neuroscience.2014.12.020","article-title":"Decreased anti-regenerative effects after spinal cord injury in spry4-\/- mice","volume":"287","author":"Goldshmit","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.jare.2025.06.024_b0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112188","article-title":"Recombinant fibroblast growth factor 4 ameliorates axonal regeneration and functional recovery in acute spinal cord injury through altering microglia\/macrophage phenotype","volume":"134","author":"Li","year":"2024","journal-title":"Int Immunopharmacol"},{"issue":"23","key":"10.1016\/j.jare.2025.06.024_b0510","doi-asserted-by":"crossref","first-page":"7016","DOI":"10.7150\/thno.37601","article-title":"An injectable heparin-laponite hydrogel bridge FGF4 for spinal cord injury by stabilizing microtubule and improving mitochondrial function","volume":"9","author":"Wang","year":"2019","journal-title":"Theranostics"},{"issue":"10","key":"10.1016\/j.jare.2025.06.024_b0515","doi-asserted-by":"crossref","first-page":"e3090","DOI":"10.1038\/cddis.2017.490","article-title":"Neuron and microglia\/macrophage-derived FGF10 activate neuronal FGFR2\/PI3K\/Akt signaling and inhibit microglia\/macrophages TLR4\/NF-\u03baB-dependent neuroinflammation to improve functional recovery after spinal cord injury","volume":"8","author":"Chen","year":"2017","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.jare.2025.06.024_b0520","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3892\/etm.2023.12039","article-title":"FGF23 alleviates neuronal apoptosis and inflammation, and promotes locomotion recovery via activation of PI3K\/AKT signalling in spinal cord injury","volume":"26","author":"Cui","year":"2023","journal-title":"Exp Ther Med"},{"issue":"48","key":"10.1016\/j.jare.2025.06.024_b0525","doi-asserted-by":"crossref","first-page":"41230","DOI":"10.1074\/jbc.M111.270470","article-title":"Acidic fibroblast growth factor (FGF) potentiates glial-mediated neurotoxicity by activating FGFR2 IIIb protein","volume":"286","author":"Lee","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jare.2025.06.024_b0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2021.104612","article-title":"Coeloglossum viride var. bracteatum extract improves cognitive deficits by restoring BDNF, FGF2 levels and suppressing RIP1\/RIP3\/MLKL-mediated neuroinflammation in a 5xFAD mouse model of Alzheimer\u2019s disease","volume":"85","author":"Li","year":"2021","journal-title":"J Funct Foods"},{"key":"10.1016\/j.jare.2025.06.024_b0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114606","article-title":"Coeloglossum viride var. bracteatum extract attenuates A\u03b2-induced toxicity by inhibiting RIP1\u2013driven inflammation and necroptosis","volume":"282","author":"Li","year":"2022","journal-title":"J Ethnopharmacol"},{"issue":"10","key":"10.1016\/j.jare.2025.06.024_b0540","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s12031-020-01600-0","article-title":"MicroRNA-107 ameliorates damage in a cell model of Alzheimer\u2019s disease by mediating the FGF7\/FGFR2\/PI3K\/Akt pathway","volume":"70","author":"Chen","year":"2020","journal-title":"J Mol Neurosci"},{"issue":"4","key":"10.1016\/j.jare.2025.06.024_b0545","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s12640-022-00523-5","article-title":"Circ-HUWE1 knockdown alleviates amyloid-\u03b2-induced neuronal injury in SK-N-SH cells via miR-433-3p release-mediated FGF7 downregulation","volume":"40","author":"Meng","year":"2022","journal-title":"Neurotox Res"},{"issue":"19","key":"10.1016\/j.jare.2025.06.024_b0550","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202400125","article-title":"BV2 membrane-coated PEGylated-liposomes delivered hFGF21 to cortical and hippocampal microglia for Alzheimer\u2019s disease therapy","volume":"13","author":"Wang","year":"2024","journal-title":"Adv Healthc Mater"},{"issue":"1","key":"10.1016\/j.jare.2025.06.024_b0555","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3233\/JAD-200837","article-title":"Neuroprotective effects of the FGF21 analogue LY2405319","volume":"80","author":"R\u00fchlmann","year":"2021","journal-title":"J Alzheimer\u2019s Dis: JAD"},{"issue":"5","key":"10.1016\/j.jare.2025.06.024_b0560","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1080\/08820139.2021.1970180","article-title":"Mechanism of the fibroblast growth factor 23\/\u03b1-Klotho axis in peripheral blood mononuclear cell inflammation in Alzheimer\u2019s disease","volume":"51","author":"Li","year":"2022","journal-title":"Immunol Invest"},{"key":"10.1016\/j.jare.2025.06.024_b0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109064","article-title":"Non-mitogenic fibroblast growth factor 1 protects against ischemic stroke by regulating microglia\/macrophage polarization through Nrf2 and NF-\u03baB pathways","volume":"212","author":"Dordoe","year":"2022","journal-title":"Neuropharmacology"},{"issue":"11","key":"10.1016\/j.jare.2025.06.024_b0570","doi-asserted-by":"crossref","first-page":"10951","DOI":"10.18632\/aging.103308","article-title":"Fibroblast growth factor 2 contributes to the effect of salidroside on dendritic and synaptic plasticity after cerebral ischemia\/reperfusion injury","volume":"12","author":"Li","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.jare.2025.06.024_b0575","doi-asserted-by":"crossref","first-page":"19869","DOI":"10.1038\/srep19869","article-title":"Neuron-derived FGF10 ameliorates cerebral ischemia injury via inhibiting NF-\u03baB-dependent neuroinflammation and activating PI3K\/Akt survival signaling pathway in mice","volume":"6","author":"Li","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jare.2025.06.024_b0580","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12974-020-01921-2","article-title":"FGF21 alleviates neuroinflammation following ischemic stroke by modulating the temporal and spatial dynamics of microglia\/macrophages","volume":"17","author":"Wang","year":"2020","journal-title":"J Neuroinflammation"},{"issue":"10","key":"10.1016\/j.jare.2025.06.024_b0585","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/cbin.11409","article-title":"Overexpression of fibroblast growth factor-21 (FGF-21) protects mesenchymal stem cells against caspase-dependent apoptosis induced by oxidative stress and inflammation","volume":"44","author":"Linares","year":"2020","journal-title":"Cell Biol Int"},{"issue":"3","key":"10.1016\/j.jare.2025.06.024_b0590","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21030824","article-title":"FGF21 protects against aggravated blood-brain barrier disruption after ischemic focal stroke in diabetic db\/db male mice via cerebrovascular PPAR\u03b3 activation","volume":"21","author":"Jiang","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jare.2025.06.024_b0595","article-title":"Mesenchymal stem cells overexpressing FGF21 preserve blood-brain Barrier integrity in experimental ischemic stroke","author":"Do","year":"2023","journal-title":"Transl Stroke Res"},{"issue":"1","key":"10.1016\/j.jare.2025.06.024_b0600","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1186\/s12967-024-05239-y","article-title":"FGF21 attenuates neuroinflammation following subarachnoid hemorrhage through promoting mitophagy and inhibiting the cGAS-STING pathway","volume":"22","author":"Ma","year":"2024","journal-title":"J Transl Med"},{"key":"10.1016\/j.jare.2025.06.024_b0605","doi-asserted-by":"crossref","unstructured":"Dobson R, Giovannoni GJEjon. Multiple sclerosis\u2013a review. 2019;26(1):27-40.","DOI":"10.1111\/ene.13819"},{"issue":"12","key":"10.1016\/j.jare.2025.06.024_b0610","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/s41573-019-0035-2","article-title":"Progressive multiple sclerosis: from pathophysiology to therapeutic strategies","volume":"18","author":"Faissner","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jare.2025.06.024_b0615","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3389\/fimmu.2015.00619","article-title":"CD8(+) T-cells as immune regulators of multiple sclerosis","volume":"6","author":"Sinha","year":"2015","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.jare.2025.06.024_b0620","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","article-title":"Multiple sclerosis","volume":"4","author":"Filippi","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.jare.2025.06.024_b0625","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1038\/s41598-021-82346-6","article-title":"B-cells expressing NgR1 and NgR3 are localized to EAE-induced inflammatory infiltrates and are stimulated by BAFF","volume":"11","author":"Bakhuraysah","year":"2021","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.jare.2025.06.024_b0630","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.neulet.2008.02.040","article-title":"Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients","volume":"435","author":"Sarchielli","year":"2008","journal-title":"Neurosci Lett"},{"issue":"2","key":"10.1016\/j.jare.2025.06.024_b0635","first-page":"201","article-title":"Fibroblast growth factor-2 levels are elevated in the serum of patients with multiple sclerosis","volume":"19","author":"Jari","year":"2022","journal-title":"Iran J Immunol"},{"issue":"13","key":"10.1016\/j.jare.2025.06.024_b0640","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25137399","article-title":"Cytokine profiling in cerebrospinal fluid of patients with newly diagnosed relapsing-remitting multiple sclerosis (RRMS): associations between inflammatory biomarkers and disease activity","volume":"25","author":"G\u0119bka-K\u0119pi\u0144ska","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.jare.2025.06.024_b0645","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1365-2567.2011.03450.x","article-title":"Neuroprotective role of fibroblast growth factor-2 in experimental autoimmune encephalomyelitis","volume":"133","author":"Rottlaender","year":"2011","journal-title":"Immunology"},{"issue":"5","key":"10.1016\/j.jare.2025.06.024_b0650","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.4103\/NRR.NRR-D-23-01620","article-title":"The role of axon guidance molecules in the pathogenesis of epilepsy","volume":"20","author":"Liu","year":"2025","journal-title":"Neural Regen Res"},{"issue":"1","key":"10.1016\/j.jare.2025.06.024_b0655","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40495-021-00270-9","article-title":"Neuroinflammation in epilepsy\u2014Diagnostics and therapeutic perspectives","volume":"8","author":"Lach","year":"2022","journal-title":"Curr Pharmacol Rep"},{"issue":"37","key":"10.1016\/j.jare.2025.06.024_b0660","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.2174\/1381612823666170926113754","article-title":"Inflammation and epilepsy: preclinical findings and potential clinical translation","volume":"23","author":"Terrone","year":"2017","journal-title":"Curr Pharm Des"},{"issue":"1","key":"10.1016\/j.jare.2025.06.024_b0665","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41593-021-00989-0","article-title":"Mitochondrial dysfunction and Parkinson\u2019s disease","volume":"25","author":"Wright","year":"2022","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.jare.2025.06.024_b0670","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2024.1431079","article-title":"Novel strategies in Parkinson\u2019s disease treatment: a review","volume":"17","author":"Mitchell","year":"2024","journal-title":"Front Mol Neurosci"},{"issue":"s1","key":"10.1016\/j.jare.2025.06.024_b0675","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.3233\/JPD-223241","article-title":"Central and peripheral inflammation: connecting the immune responses of Parkinson\u2019s disease","volume":"12","author":"Williams","year":"2022","journal-title":"J Parkinsons Dis"},{"issue":"11","key":"10.1016\/j.jare.2025.06.024_b0680","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"10.1016\/j.jare.2025.06.024_b0685","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41582-023-00867-2","article-title":"The amyotrophic lateral sclerosis exposome: recent advances and future directions","volume":"19","author":"Goutman","year":"2023","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.jare.2025.06.024_b0690","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12883-022-02730-1","article-title":"Serum biomarkers of neuroinflammation and blood-brain barrier leakage in amyotrophic lateral sclerosis","volume":"22","author":"Cao","year":"2022","journal-title":"BMC Neurol"},{"issue":"6","key":"10.1016\/j.jare.2025.06.024_b0695","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1468-1331.2009.02560.x","article-title":"Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis","volume":"16","author":"Kuhle","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jare.2025.06.024_b0700","doi-asserted-by":"crossref","unstructured":"McGeer P, McGeer EJM, Medicine NOJotAAoE. Inflammatory processes in amyotrophic lateral sclerosis. 2002;26(4):459-70.","DOI":"10.1002\/mus.10191"},{"key":"10.1016\/j.jare.2025.06.024_b0705","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3389\/fimmu.2017.01005","article-title":"Role of neuroinflammation in amyotrophic lateral sclerosis: cellular mechanisms and therapeutic implications","volume":"8","author":"Liu","year":"2017","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.jare.2025.06.024_b0710","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/j.pain.0000000000001122","article-title":"Inflammation in the pathophysiology of neuropathic pain","volume":"159","author":"Sommer","year":"2018","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.jare.2025.06.024_b0715","first-page":"101","article-title":"Inflammatory response in acute traumatic brain injury: a double-edged sword","volume":"8","author":"Morganti-Kossmann","year":"2002","journal-title":"Curr Opin Crit Care"},{"issue":"1","key":"10.1016\/j.jare.2025.06.024_b0720","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1055\/s-2008-1040908","article-title":"Neuroborreliosis: central nervous system involvement","volume":"17","author":"Halperin","year":"1997","journal-title":"Semin Neurol"},{"key":"10.1016\/j.jare.2025.06.024_b0725","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1742-2094-9-72","article-title":"A possible role for inflammation in mediating apoptosis of oligodendrocytes as induced by the Lyme disease spirochete Borrelia burgdorferi","volume":"9","author":"Ramesh","year":"2012","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.jare.2025.06.024_b0730","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1146\/annurev-clinpsy-072220-021440","article-title":"Major depression and its recurrences: life course matters","volume":"18","author":"Monroe","year":"2022","journal-title":"Annu Rev Clin Psychol"},{"key":"10.1016\/j.jare.2025.06.024_b0735","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/1741-7015-11-200","article-title":"So depression is an inflammatory disease, but where does the inflammation come from?","volume":"11","author":"Berk","year":"2013","journal-title":"BMC Med"},{"issue":"2","key":"10.1016\/j.jare.2025.06.024_b0740","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neuron.2020.06.002","article-title":"The bidirectional relationship of depression and inflammation: double trouble","volume":"107","author":"Beurel","year":"2020","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.jare.2025.06.024_b0745","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1152\/physrev.00045.2019","article-title":"Neuropathic pain: from mechanisms to treatment","volume":"101","author":"Finnerup","year":"2021","journal-title":"Physiol Rev"},{"issue":"2","key":"10.1016\/j.jare.2025.06.024_b0750","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.brainresrev.2005.11.004","article-title":"Immune and inflammatory mechanisms in neuropathic pain","volume":"51","author":"Moalem","year":"2006","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.jare.2025.06.024_b0755","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.neures.2017.08.009","article-title":"The roles of cortical astrocytes in chronic pain and other brain pathologies","volume":"126","author":"Eto","year":"2018","journal-title":"Neurosci Res"},{"issue":"9304","key":"10.1016\/j.jare.2025.06.024_b0760","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0140-6736(02)07603-1","article-title":"Spinal-cord injury","volume":"359","author":"McDonald","year":"2002","journal-title":"Lancet (London, England)"},{"issue":"Pt 2","key":"10.1016\/j.jare.2025.06.024_b0765","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/brain\/awp322","article-title":"Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment","volume":"133","author":"Beck","year":"2010","journal-title":"Brain J Neurol"},{"issue":"25","key":"10.1016\/j.jare.2025.06.024_b0770","doi-asserted-by":"crossref","first-page":"11376","DOI":"10.7150\/thno.49199","article-title":"Delayed microglial depletion after spinal cord injury reduces chronic inflammation and neurodegeneration in the brain and improves neurological recovery in male mice","volume":"10","author":"Li","year":"2020","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.jare.2025.06.024_b0775","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.12056","article-title":"Acute spinal cord injury: pathophysiology and pharmacological intervention (review)","volume":"23","author":"Zhang","year":"2021","journal-title":"Mol Med Rep"},{"issue":"7","key":"10.1016\/j.jare.2025.06.024_b0780","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nrn3053","article-title":"Repertoire of microglial and macrophage responses after spinal cord injury","volume":"12","author":"David","year":"2011","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"10.1016\/j.jare.2025.06.024_b0785","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer\u2019s disease","volume":"25","author":"Lane","year":"2018","journal-title":"Eur J Neurol"},{"issue":"4","key":"10.1016\/j.jare.2025.06.024_b0790","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.jare.2025.06.024_b0795","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrn3880","article-title":"Immune attack: the role of inflammation in Alzheimer disease","volume":"16","author":"Heppner","year":"2015","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"10.1016\/j.jare.2025.06.024_b0800","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/jnr.24996","article-title":"Normal aging, motor neurone disease, and Alzheimer\u2019s disease are characterized by cortical changes in inflammatory cytokines","volume":"100","author":"Tennakoon","year":"2022","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.jare.2025.06.024_b0805","article-title":"BV2 membrane\u2010coated PEGylated\u2010liposomes delivered hFGF21 to cortical and hippocampal microglia for Alzheimer\u2019s disease therapy","author":"Wang","year":"2024","journal-title":"Adv Healthc Mater"},{"issue":"9","key":"10.1016\/j.jare.2025.06.024_b0810","first-page":"561","article-title":"Stroke: causes and clinical features","volume":"48","author":"Murphy","year":"2020","journal-title":"Medicine (Abingdon, England: UK ed)"},{"issue":"11","key":"10.1016\/j.jare.2025.06.024_b0815","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S1474-4422(19)30078-X","article-title":"Global brain inflammation in stroke","volume":"18","author":"Shi","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jare.2025.06.024_b0820","doi-asserted-by":"crossref","unstructured":"Shirvanchi K, Gurski F, Rajendran V, Rajendran R, Megalofonou F-F, Stadelmann-Nessler C, et al., editors. The Multi-kinase Inhibitor AZD4547 Reduces Inflammation and Neurodegeneration, and Enhances Remyelination in a Mouse Model of Multiple Sclerosis (P7-6.008). Neurology; 2024: AAN Enterprises.","DOI":"10.1212\/WNL.0000000000205039"},{"key":"10.1016\/j.jare.2025.06.024_b0825","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1200\/JCO.2016.67.2048","volume":"35","author":"Nogova","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jare.2025.06.024_b0830","doi-asserted-by":"crossref","first-page":"7225","DOI":"10.2147\/IJN.S417723","article-title":"Modified FGF hydrogel for effective axon formation by enhanced regeneration of myelin sheath of schwann cells using rat model","volume":"18","author":"Li","year":"2023","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.jare.2025.06.024_b0835","unstructured":"Lam S, Li Y, Zheng C, Leung L, Ho J, editors. Combination effect of arsenic trioxide and FGFR inhibitor through downregulation of FGFR, Akt and Erk in squamous cell lung carcinoma. Hong Kong International Cancer Congress, HKICC 2014; 2014."},{"issue":"3","key":"10.1016\/j.jare.2025.06.024_b0840","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3892\/ijmm_00000132","article-title":"FGFR2-related pathogenesis and FGFR2-targeted therapeutics","volume":"23","author":"Katoh","year":"2009","journal-title":"Int J Mol Med"},{"issue":"5","key":"10.1016\/j.jare.2025.06.024_b0845","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/sj.leu.2403347","article-title":"Targeting FGFR3 in multiple myeloma: inhibition of t(4;14)-positive cells by SU5402 and PD173074","volume":"18","author":"Grand","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.jare.2025.06.024_b0850","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3389\/fnins.2018.00582","article-title":"Inhibitive effects of FGF2\/FGFR1 pathway on astrocyte-mediated inflammation in vivo and in vitro after infrasound exposure","volume":"12","author":"Shi","year":"2018","journal-title":"Front Neurosci"},{"issue":"1","key":"10.1016\/j.jare.2025.06.024_b0855","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0022-3565(24)37619-0","article-title":"In vitro biological characterization and antiangiogenic effects of PD 166866, a selective inhibitor of the FGF-1 receptor tyrosine kinase","volume":"286","author":"Panek","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"10.1016\/j.jare.2025.06.024_b0860","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/cmdc.201700718","article-title":"Discovery of Rogaratinib (BAY 1163877): a pan-FGFR inhibitor","volume":"13","author":"Collin","year":"2018","journal-title":"ChemMedChem"},{"issue":"11","key":"10.1016\/j.jare.2025.06.024_b0865","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1001\/jamaoncol.2024.3900","article-title":"Rogaratinib plus atezolizumab in cisplatin-ineligible patients with FGFR RNA-overexpressing urothelial cancer: the FORT-2 phase 1b nonrandomized clinical trial","volume":"10","author":"Sweis","year":"2024","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jare.2025.06.024_b0870","unstructured":"Infigratinib. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012."},{"issue":"23","key":"10.1016\/j.jare.2025.06.024_b0875","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1111\/bph.16186","article-title":"The small molecule fibroblast growth factor receptor inhibitor infigratinib exerts anti-inflammatory effects and remyelination in a model of multiple sclerosis","volume":"180","author":"Rajendran","year":"2023","journal-title":"Br J Pharmacol"},{"issue":"8","key":"10.1016\/j.jare.2025.06.024_b0880","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1158\/0008-5472.CAN-11-3034","article-title":"AZD4547: an orally bioavailable, potent, and selective inhibitor of the fibroblast growth factor receptor tyrosine kinase family","volume":"72","author":"Gavine","year":"2012","journal-title":"Cancer Res"},{"issue":"14_Supplement","key":"10.1016\/j.jare.2025.06.024_b0885","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1158\/1538-7445.AM2016-1174","article-title":"AZD4547 and AZD5363 synergistically inhibit prostate cancer progression by modulating MAPK and AKT activation","volume":"76(","author":"Feng","year":"2016","journal-title":"Cancer Res"},{"issue":"18","key":"10.1016\/j.jare.2025.06.024_b0890","first-page":"13770","article-title":"The inhibition of the FGFR\/PI3K\/Akt Axis by AZD4547 disrupts the proangiogenic microenvironment and vasculogenic mimicry arising from the interplay between endothelial and triple-negative breast","volume":"24","author":"Morales-Guadarrama","year":"2023","journal-title":"Cancer Cells"},{"issue":"4","key":"10.1016\/j.jare.2025.06.024_b0895","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s41401-022-00993-5","article-title":"Repurposing of the FGFR inhibitor AZD4547 as a potent inhibitor of necroptosis by selectively targeting RIPK1","volume":"44","author":"Wang","year":"2023","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.jare.2025.06.024_b0900","doi-asserted-by":"crossref","unstructured":"Bianco PJAroc, biology d. \u201cMesenchymal\u201d stem cells. 2014;30(1):677\u2013704.","DOI":"10.1146\/annurev-cellbio-100913-013132"},{"issue":"8","key":"10.1016\/j.jare.2025.06.024_b0905","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2217\/rme-2021-0168","article-title":"Mesenchymal stem cell application for treatment of neuroinflammation-induced cognitive impairment in mice","volume":"17","author":"Skok","year":"2022","journal-title":"Regen Med"},{"issue":"2","key":"10.1016\/j.jare.2025.06.024_b0910","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrd3660","article-title":"An FGFR antibody with long-lasting effects","volume":"11","author":"Harrison","year":"2012","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"10.1016\/j.jare.2025.06.024_b0915","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065763","article-title":"LY2405319, an engineered FGF21 variant, improves the metabolic status of diabetic monkeys","volume":"8","author":"Adams","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jare.2025.06.024_b0920","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41576-023-00662-1","article-title":"Non-coding RNAs in disease: from mechanisms to therapeutics","volume":"25","author":"Nemeth","year":"2024","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.jare.2025.06.024_b0925","unstructured":"An YXJJoES. Circular RNA regulation of CNS neuroinflammatory mechanisms. 2024;20(10s):1009-18."},{"key":"10.1016\/j.jare.2025.06.024_b0930","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109268","article-title":"Salidroside: a review of its recent advances in synthetic pathways and pharmacological properties","volume":"339","author":"Zhang","year":"2021","journal-title":"Chem Biol Interact"},{"issue":"6","key":"10.1016\/j.jare.2025.06.024_b0935","first-page":"407","article-title":"Progress on the pharmacological research of puerarin: a review","volume":"12","author":"Wei","year":"2014","journal-title":"Chin J Nat Med"},{"issue":"7","key":"10.1016\/j.jare.2025.06.024_b0940","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/ptr.5083","article-title":"Puerarin: a review of pharmacological effects","volume":"28","author":"Zhou","year":"2014","journal-title":"Phytother Res: PTR"},{"key":"10.1016\/j.jare.2025.06.024_b0945","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115257","article-title":"Pharmacological activities and pharmacokinetics of liquiritin: a review","volume":"293","author":"Qin","year":"2022","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.jare.2025.06.024_b0950","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116772","article-title":"Antioxidant effects of paeoniflorin and relevant molecular mechanisms as related to a variety of diseases: a review","volume":"176","author":"Lu","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jare.2025.06.024_b0955","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fphar.2017.00024","article-title":"A systemic review of the ethnobotany, phytochemistry, and pharmacology of an important Asian folk medicine","volume":"8","author":"Shang","year":"2017","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.jare.2025.06.024_b0960","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173814","article-title":"Implantable porous gelatin microspheres sustained release of bFGF and improved its neuroprotective effect on rats after spinal cord injury","volume":"12","author":"Lan","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jare.2025.06.024_b0965","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10787-022-01115-7","article-title":"Exosome engineering in cell therapy and drug delivery","volume":"31","author":"Sadeghi","year":"2023","journal-title":"Inflammopharmacology"},{"issue":"9","key":"10.1016\/j.jare.2025.06.024_b0970","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24097736","article-title":"Viral vector-based gene therapy","volume":"24","author":"Li","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"14","key":"10.1016\/j.jare.2025.06.024_b0975","doi-asserted-by":"crossref","first-page":"5740","DOI":"10.1039\/D2CS00200K","article-title":"Target and tissue selectivity of PROTAC degraders","volume":"51","author":"Guenette","year":"2022","journal-title":"Chem Soc Rev"},{"issue":"4","key":"10.1016\/j.jare.2025.06.024_b0980","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ccr.2013.02.019","article-title":"Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties","volume":"23","author":"Bono","year":"2013","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.jare.2025.06.024_b0985","doi-asserted-by":"crossref","first-page":"585","DOI":"10.4155\/ppa.14.45","article-title":"Approaches targeting the FGF-FGFR system: a review of the recent patent literature and associated advanced therapeutic agents","volume":"3","author":"Herbert","year":"2014","journal-title":"Pharm Pat Anal"},{"issue":"4","key":"10.1016\/j.jare.2025.06.024_b0990","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2013006955","article-title":"Peptide and protein delivery using new drug delivery systems","volume":"30","author":"Jain","year":"2013","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"issue":"1","key":"10.1016\/j.jare.2025.06.024_b0995","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/14712598.2024.2436094","article-title":"Strategies for extending the half-life of biotherapeutics: successes and complications","volume":"25","author":"Binder","year":"2025","journal-title":"Expert Opin Biol Ther"},{"issue":"7","key":"10.1016\/j.jare.2025.06.024_b1000","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.addr.2011.11.002","article-title":"Intranasal delivery of biologics to the central nervous system","volume":"64","author":"Lochhead","year":"2012","journal-title":"Adv Drug Deliv Rev"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123225004321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123225004321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T08:22:02Z","timestamp":1764231722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123225004321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":200,"alternative-id":["S2090123225004321"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2025.06.024","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FGFs\/FGFRs and neuroinflammatory diseases: mechanism, drug therapies and delivery systems","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2025.06.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}